| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Department of Surgery and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322
It is well known that dysfunction of the apoptotic pathway confers apoptosis resistance and results in a low sensitivity of human cancer cells to therapeutic agents. A novel strategy to overcome the resistance is to target the apoptotic pathway directly. To identify molecular targets in the apoptotic pathway that are differentially regulated in cancer and normal cells, we have examined the levels of apoptotic effectors and inhibitors in human tumor and normal cell lines as well as in cancer and normal tissues. These include three pancreatic cancer lines (BXPC-3, MIA PaCa-2, and Panc-1), four breast cancer cell lines (MDA-MB-231, MDA-MB-435, MDA-MB-361, and MCF-7), and colon carcinoma line (SW620). Additionally, breast carcinoma tissue specimens were examined. Compared with normal human fibroblast and mammary epithelial cell lines, we detected high basal levels of caspase-3 and caspase-8 activities and active caspase-3 fragments in the tumor cell lines and cancer tissues in the absence of apoptotic stimuli. Furthermore, the tumor cells expressed high levels of survivin and XIAP, two members of the inhibitor of apoptosis (IAP) protein family. When the activity of these IAPs was blocked by expression of dominant-negative mutant survivin (survivinT34A) and XIAP-associated factor 1, respectively, apoptosis was induced in tumor but not normal cell lines. Moreover, down-regulation of both survivin and XIAP significantly enhanced tumor-cell apoptosis as compared with inhibition of either survivin or XIAP alone. These results suggest that up-regulated IAP expression counteracts the high basal caspase-3 activity observed in these tumor cells and that apoptosis in tumor cells but not normal cells can be induced by blocking IAP activity. Therefore, IAPs are important molecular targets for the development of cancer-specific therapeutic approaches.
This article has been cited by other articles:
|
|
 |
|
  T. Hashimoto, L. Yamauchi, T. Hunter, U. Kikkawa, and S. Kamada Possible involvement of caspase-7 in cell cycle progression at mitosis. Genes Cells, June 1, 2008; 13(6): 609 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, X. Cai, X. Fan, B. Moquin, C. Stoicov, and J. Houghton Fas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cells Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G263 - G275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gdynia, K. Grund, A. Eckert, B. C. Bock, B. Funke, S. Macher-Goeppinger, S. Sieber, C. Herold-Mende, B. Wiestler, O. D. Wiestler, et al. Basal Caspase Activity Promotes Migration and Invasiveness in Glioblastoma Cells Mol. Cancer Res., December 1, 2007; 5(12): 1232 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Vucic and W. J. Fairbrother The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer Clin. Cancer Res., October 15, 2007; 13(20): 5995 - 6000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Esposito, J. Kleeff, I. Abiatari, X. Shi, N. Giese, F. Bergmann, W. Roth, H. Friess, and P. Schirmacher Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer J. Clin. Pathol., August 1, 2007; 60(8): 885 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Prickett and D. L. Brautigan Cytokine Activation of p38 Mitogen-Activated Protein Kinase and Apoptosis Is Opposed by alpha-4 Targeting of Protein Phosphatase 2A for Site-Specific Dephosphorylation of MEK3 Mol. Cell. Biol., June 15, 2007; 27(12): 4217 - 4227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Suzuki, T. Nishi, T. Nagino, K. Sasaki, K. Aizawa, N. Kada, D. Sawaki, Y. Munemasa, T. Matsumura, S. Muto, et al. Functional Interaction between the Transcription Factor Kruppel-like Factor 5 and Poly(ADP-ribose) Polymerase-1 in Cardiovascular Apoptosis J. Biol. Chem., March 30, 2007; 282(13): 9895 - 9901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. C. Wong, W. P. Tsang, P. Y. Chau, N. N. Co, T. Y. Tsang, and T. T. Kwok p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3 Mol. Cancer Ther., March 1, 2007; 6(3): 1054 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Karikari, I. Roy, E. Tryggestad, G. Feldmann, C. Pinilla, K. Welsh, J. C. Reed, E. P. Armour, J. Wong, J. Herman, et al. Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein Mol. Cancer Ther., March 1, 2007; 6(3): 957 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-H. Peng, P. Karna, R. M. O'Regan, X. Liu, R. Naithani, R. M. Moriarty, W. C. Wood, H.-Y. Lee, and L. Yang Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells Mol. Pharmacol., January 1, 2007; 71(1): 101 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Braeuer, C. Buneker, A. Mohr, and R. M. Zwacka Constitutively Activated Nuclear Factor-{kappa}B, but not Induced NF-{kappa}B, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells Mol. Cancer Res., October 1, 2006; 4(10): 715 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-H. Peng, P. Karna, Z. Cao, B.-H. Jiang, M. Zhou, and L. Yang Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1{alpha} Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene Expression J. Biol. Chem., September 8, 2006; 281(36): 25903 - 25914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Cheung, E. C. LaCasse, and R. G. Korneluk X-linked inhibitor of apoptosis antagonism: strategies in cancer treatment. Clin. Cancer Res., June 1, 2006; 12(11): 3238 - 3242. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Helfer, B. C. Boswell, D. Finlay, A. Cipres, K. Vuori, T. Bong Kang, D. Wallach, A. Dorfleutner, J. M. Lahti, D. C. Flynn, et al. Caspase-8 Promotes Cell Motility and Calpain Activity under Nonapoptotic Conditions. Cancer Res., April 15, 2006; 66(8): 4273 - 4278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Taguchi, T Takao, Y Iwasaki, M Nishiyama, K Asaba, and K Hashimoto Suppressive effects of dehydroepiandrosterone and the nuclear factor-{kappa}B inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo J. Endocrinol., February 1, 2006; 188(2): 321 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takeuchi, J. Kim, A. Fujimoto, N. Umetani, T. Mori, A. Bilchik, R. Turner, A. Tran, C. Kuo, and D. S.B. Hoon X-Linked Inhibitor of Apoptosis Protein Expression Level in Colorectal Cancer Is Regulated by Hepatocyte Growth Factor/C-Met Pathway via Akt Signaling Clin. Cancer Res., November 1, 2005; 11(21): 7621 - 7628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mukai, T. Kusama, Y. Hamanaka, T. Koga, H. Endo, M. Tatsuta, and M. Inoue Cross Talk between Apoptosis and Invasion Signaling in Cancer Cells through Caspase-3 Activation Cancer Res., October 15, 2005; 65(20): 9121 - 9125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Z. Carter, M. Gronda, Z. Wang, K. Welsh, C. Pinilla, M. Andreeff, W. D. Schober, A. Nefzi, G. R. Pond, I. A. Mawji, et al. Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells Blood, May 15, 2005; 105(10): 4043 - 4050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Konishi, S. Sasaki, T. Watanabe, J. Kitayama, and H. Nagawa Overexpression of hRFI (human ring finger homologous to inhibitor of apoptosis protein type) inhibits death receptor-mediated apoptosis in colorectal cancer cells Mol. Cancer Ther., May 1, 2005; 4(5): 743 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zi and A. R. Simoneau Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice Cancer Res., April 15, 2005; 65(8): 3479 - 3486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Fennell Caspase Regulation in Non-Small Cell Lung Cancer and its Potential for Therapeutic Exploitation Clin. Cancer Res., March 15, 2005; 11(6): 2097 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-H. Peng, Z.-H. Cao, J.-T. Xia, G. W. Carlson, M. M. Lewis, W. C. Wood, and L. Yang Real-time Detection of Gene Expression in Cancer Cells Using Molecular Beacon Imaging: New Strategies for Cancer Research Cancer Res., March 1, 2005; 65(5): 1909 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Srinivasan and W. M. Linehan Targeted for Destruction: The Molecular Basis for Development of Novel Therapeutic Strategies in Renal Cell Cancer J. Clin. Oncol., January 20, 2005; 23(3): 410 - 412. [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation J. Biol. Chem., June 4, 2004; 279(23): 24015 - 24023. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
